Significant changes were found in the immune cell levels of children with juvenile idiopathic arthritis (JIA) following treatment with methotrexate and Humira (adalimumab), a study reports. These findings help explain the increased risk of infection upon treatment with medicines that work in the same way as Humira, researchers said. The study, “Peripheral Blood Lymphocyte Analysis in Oligo- and Polyarticular Juvenile Idiopathic Arthritis Patients Receiving Methotrexate or Adalimumab Therapy: A Cross-Sectional Study,” was published in the…

You must be logged in to read/download the full post.